NASDAQ •
Healthcare •
Biotechnology •
Quote as of 06/18/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization35.1 mln
Float20.44 mln
Earnings Date08/13/2026
Piotroski F-Score
1
/ 9
Very weak
Relative Strength
36
/ 100
Underperforming
Debt / Equity
0.25
Very low leverage
ROE
-93.03
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
ABVC BioPharma is a California-based company working to bring new treatments to patients with serious conditions that currently have few good options. The company has a broad pipeline of drugs and medical devices moving through clinical trials, targeting areas such as breast cancer, depression, ADHD, lung cancer, pancreatic cancer, and eye conditions. ABVC advances its work through partnerships with several life sciences organizations, combining shared resources and expertise to move its products closer to market.
